Plan delivery quality assurance for CyberKnife: Statistical process control analysis of 350 film-based patient-specific QAs

Authors: Bellec, J., Delaby, N., Jouyaux, F., Perdrieux, M., Bouvier, J., Sorel, S., Henry, O., Lafond, C.

Source: In Physica Medica July 2017 39:50-58

CyberKnife® M6™: Peripheral dose evaluation for brain treatments

Authors: Delaby, N., Bellec, J., Bouvier, J., Jouyaux, F., Perdrieux, M., Castelli, J., Lecouillard, I., Manens, J.P., Lafond, C.

Source: In Physica Medica May 2017 37:88-96

Bénéfice attendu du curage ganglionnaire et de l’exérèse des vésicules séminales pour diminuer la toxicité de la radiothérapie des tumeurs prostatiques de haut risque

Alternate Title: Expected benefit of lymph node and seminal vesical dissection to decrease high-risk prostate cancer radiotherapy (English)

Authors: Colliaux, J., Kharchi, L., Vincendeau, S., Simon, A., Perdrieux, M., Le Prisé, É., Bellisant, É., Castelli, J., de Crevoisier, R.

Source: In Cancer / Radiothérapie July 2016 20(5):347-356

Quelle RCMI ? Du « step and shoot » au VMAT : point de vue du physicien

Alternate Title: Which IMRT? From “step and shoot” to VMAT: Physicist point of view (English)

Authors: Lafond, C., Jouyaux, F., Bellec, J., Henry, O., Perdrieux, M., Chajon, E., Le Prisé, É., de Crevoisier, R., Manens, J.-P.

Source: In Cancer / Radiothérapie 2010 14(6):539-549

Quelle RCMI ? Du >au VMAT : point de vue du physicien

Authors: Lafond, C., Jouyaux, F., Bellec, J., Henry, O., Perdrieux, M., Chajon, E., Le Prise, E., de Crevoisier, R., Manens, J. P.

Source: CANCER RADIOTHRTAPIE. 14(6-7):539-549

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN278931650&indx=1&recIds=ETOCRN278931650

41. Stereotactic radiotherapy for brain metastases: Cyberknife® rsaHD®/ ExacTrac®

Authors: Perdrieux, M., Céleste, M., Lecouillard, I., Nouhaud, E., Blay, C., Jouyaux, F., Delaby, N., Bellec, J., Lafond, C.

Source: PHYSICA MEDICA. 32(SUPP/4):360-361

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382457789&indx=1&recIds=ETOCRN382457789

EP-1622: Cyberknife® M6TM: peripheral dose evaluation in brain treatments

Authors: Delaby, N., Bellec, J., Bouvier, J., Jouyaux, F., Perdrieux, M., Castelli, J., Lecouillard, I., Blot, V., Manens, J.P., Lafond, C.

Source: Radiotherapy and oncology. 119:S755-S756

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100034920647.0x000001&indx=1&recIds=ETOCvdc_100034920647.0x000001

64 Management of the medical physics students in internship: Feedback of Centre Eugène Marquis (Regional Cancer Center of Rennes/France)

Authors: Lafond, C., Laffont, S., Bellec, J., Henry, O., Perdrieux, M., Jouyaux, F., Perichon, N., Delaby, N., Hervé, C.

Source: Physica medica. 56(S1):36-36

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100073662387.0x000001&indx=1&recIds=ETOCvdc_100073662387.0x000001

40. Evaluation of the Incise2™ multileaf collimator for stereotactic radiotherapy on Cyberknife®

Authors: Bellec, J., Limoges, C., Delaby, N., Perdrieux, M., Jouyaux, F., Lafond, C.

Source: PHYSICA MEDICA. 32(SUPP/4):360-

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382457880&indx=1&recIds=ETOCRN382457880

PO-0919: Stereotactic radiotherapy for brain metastases : Cyberknife versus VersaHD / ExacTrac

Authors: Perdrieux, M., Celeste, M., Lecouillard, I., Nouhaud, E., Blay, C., Jouyaux, F., Delaby, N., Bellec, J., Lafond, C.

Source: In Radiotherapy and Oncology May 2017 123 Supplement 1:S509-S509

PO-0826: Evaluation of the new InCise MLC for Cyberknife stereotactic radiotherapy

Authors: Limoges, C., Bellec, J., Delaby, N., Perdrieux, M., Jouyaux, F., Nouhaud, E., Lecouillard, I., Chajon, E., De Crevoisier, R., Le Prisé, E., Lafond, C.

Source: In Radiotherapy and Oncology May 2017 123 Supplement 1:S444-S444

Practical implementation of a patient specific QA on Cyberknife using Gafchromic® EBT3 film: One-year results analysis

Authors: Bellec, J., Jouyaux, F., Perdrieux, M., Sorel, S., Lesnard, J., Henry, O., Manens, J. P., Lafond, C.

Source: PHYSICA MEDICA. 31(SUPP/2):e33-

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN373274699&indx=1&recIds=ETOCRN373274699

25 - Practical implementation of a patient specific QA on Cyberknife using Gafchromic® EBT3 film: One-year results analysis

Authors: Bellec, J., Jouyaux, F., Perdrieux, M., Sorel, S., Lesnard, J., Henry, O., Manens, J.P., Lafond, C.

Source: In Physica Medica November 2015 31 Supplement 2:e33-e33

OC-0565: Identification of a rectal sub-region at risks of toxicity in prostate cancer radiotherapy

Authors: Dréan, G., Acosta, O., Ospina, J.D., Simon, A., Lafond, C., Henry, O., Perdrieux, M., Haigron, P., De Crevoisier, R.

Source: In Radiotherapy and Oncology April 2015 115 Supplement 1:S276-S276

PO-0718: Impact of lymph node and seminal vesicles dissection before prostate cancer radiotherapy to decrease toxicity

Authors: Colliaux, J., Kharchi, L., Vincendeau, S., Simon, A., Perdrieux, M., Le Prisé, E., Acosta, O., Bellissant, E., Castelli, J., de Crevoisier, R.

Source: In Radiotherapy and Oncology March 2013 106 Supplement 2:S275-S275

Evaluation of influence of several arc parameters on dosimetric agreement for VMAT technique

Authors: Lafond, C., Jouyaux, F., Henry, O., Perdrieux, M., Sorel, S., Bellec, J., Olivier, M., Toublanc, S., Lesaunier, M., Manens, J.-P.

Source: In Physica Medica 2011 27 Supplement 1:S4-S4

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.